3-(2,4-dimethoxybenzylidene)-anabaseine: a promising candidate drug for Alzheimer's disease?

Geriatr Gerontol Int. 2012 Jul;12(3):365-71. doi: 10.1111/j.1447-0594.2011.00827.x. Epub 2012 Feb 2.

Abstract

3-(2,4-dimethoxybenzylidene)-anabaseine is an analog of the paralytic alkaloid, anabaseine, from the ribbon worms Amphiporus sp., that shows numerous properties, in particular an agonist activity on alpha 7 nicotinic acetylcholine receptors. This article reviews these properties and explains to what extent they could be valuable to control symptomatology and/or neurodegeneration in Alzheimer's disease.

Publication types

  • Review

MeSH terms

  • Alzheimer Disease / drug therapy*
  • Benzylidene Compounds / pharmacology*
  • Humans
  • Nicotinic Agonists / pharmacology*
  • Pyridines / pharmacology*

Substances

  • Benzylidene Compounds
  • Nicotinic Agonists
  • Pyridines
  • 3-(2,4-dimethoxybenzylidene)anabaseine